These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 927488

  • 1. The linear array.
    Zubrod CG, Schepartz SA, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar; (45):13-4. PubMed ID: 927488
    [No Abstract] [Full Text] [Related]

  • 2. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S, Wittes R.
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract] [Full Text] [Related]

  • 3. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.
    Venditti JM.
    Cancer Treat Rep; 1983 Sep; 67(9):767-72. PubMed ID: 6883352
    [No Abstract] [Full Text] [Related]

  • 4. Screening at the National Cancer Institute.
    Goldin A, Venditti JM, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract] [Full Text] [Related]

  • 5. Historical background of the National Cancer Institute's drug development thrust.
    Zubrod CG, Schepartz SA, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar; (45):7-11. PubMed ID: 337156
    [No Abstract] [Full Text] [Related]

  • 6. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
    Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
    [No Abstract] [Full Text] [Related]

  • 7. [Past and current problems in tumor research].
    von Wasielewski E, Sedlacek HH.
    Dtsch Med Wochenschr; 1986 Apr 18; 111(16):630-7. PubMed ID: 3956405
    [No Abstract] [Full Text] [Related]

  • 8. [Models and methods used for the selection of antitumor preparations in the USSR and abroad].
    Sof'ina ZP.
    Vopr Onkol; 1976 Apr 18; 22(4):82-96. PubMed ID: 1274284
    [No Abstract] [Full Text] [Related]

  • 9. Clinical testing of drugs for cancer in the United States and the Soviet Union.
    Holland JF.
    Natl Cancer Inst Monogr; 1977 Mar 18; (45):261-2. PubMed ID: 927493
    [No Abstract] [Full Text] [Related]

  • 10. [Soviet-American cooperation in experimental and clinical chemotherapy from 1972 to 1979].
    Peredovchikova NI, Kiselev AV, Puchkov IuI, Komarova LE, Gorbunova VA.
    Vopr Onkol; 1980 Mar 18; 26(12):3-6. PubMed ID: 7008350
    [No Abstract] [Full Text] [Related]

  • 11. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1984 May 18; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract] [Full Text] [Related]

  • 12. Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.
    Geran RI, Greenberg NH, Macdonald MM, Abbott BJ.
    Natl Cancer Inst Monogr; 1977 Mar 18; (45):151-3. PubMed ID: 927490
    [No Abstract] [Full Text] [Related]

  • 13. Proceedings: Anticancer drug development programs: a comparison of approaches in the United States, the Soviet Union, Japan, and Western Europe.
    Carter SK.
    Natl Cancer Inst Monogr; 1974 Feb 18; 40():31-45. PubMed ID: 4819407
    [No Abstract] [Full Text] [Related]

  • 14. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS.
    Cancer Treat Rep; 1984 Jan 18; 68(1):63-76. PubMed ID: 6692438
    [Abstract] [Full Text] [Related]

  • 15. The discovery and development of new antileukemic drugs.
    Grever M, Malspeis L.
    Hematol Oncol Clin North Am; 1993 Feb 18; 7(1):233-54. PubMed ID: 8449860
    [Abstract] [Full Text] [Related]

  • 16. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ, Young DM, Davis RD, Cooney DA, Guarino AM.
    Natl Cancer Inst Monogr; 1977 Mar 18; (45):159-77. PubMed ID: 412104
    [No Abstract] [Full Text] [Related]

  • 17. The NCI Developmental Therapeutics Program.
    Collins JM.
    Clin Adv Hematol Oncol; 2006 Apr 18; 4(4):271-3. PubMed ID: 16728938
    [No Abstract] [Full Text] [Related]

  • 18. Reader comments on complementary and alternative medicine programs.
    Lee CO.
    Clin J Oncol Nurs; 2005 Oct 18; 9(5):510; author reply 510-1. PubMed ID: 16235577
    [No Abstract] [Full Text] [Related]

  • 19. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan 18; 68(1):343-56. PubMed ID: 6692435
    [No Abstract] [Full Text] [Related]

  • 20. Sounding board. Clinical evaluation of Laetrile: two perspectives. Why the National Cancer Institute chooses a case-record review of Laetrile.
    Newell GR.
    N Engl J Med; 1978 Jan 26; 298(4):216-8. PubMed ID: 339089
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.